RUSSELL SKIBSTED
CIK 1308105 · Chief Financial Officer · last filed 2026-07-01
RUSSELL SKIBSTED is a Chief Financial Officer who has filed 25 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing shows the insider bought $6.3K of PCSA on Jul 1, 2026. Across all open-market trades the lifetime net is +$47.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $50.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$50.9K
4
25
$47.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCSA | Chief Financial Officer | 16,689 | $3.05 | $50.9K | $41.7K | 11 | 2026-07-01 |
| ALIMERA SCIENCES INC (ALIM) Delisted | Chief Financial Officer & SVP | 75,500 | $5.54 | $418.3K | $0 | 3 | 2023-11-28 |
| RMTI | See Remarks | — | $6.99 | — | $0 | 2 | 2022-09-13 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Chief Financial Officer | 2,000 | — | — | $5.3K | 4 | 2018-03-19 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-01 | PCSA | Buy (P) | +3,277 | $6.3K | EDGAR |
| 2026-06-16 | PCSA | Buy (P) | +2,654 | $5.9K | EDGAR |
| 2026-06-01 | PCSA | Buy (P) | +2,292 | $5.9K | EDGAR |
| 2026-05-19 | PCSA | Buy (P) | +1,984 | $5.9K | EDGAR |
| 2026-05-01 | PCSA | Buy (P) | +2,190 | $5.9K | EDGAR |
| 2026-04-17 | PCSA | Buy (P) | +1,984 | $5.9K | EDGAR |
| 2026-04-01 | PCSA | Buy (P) | +2,324 | $5.9K | EDGAR |
| 2025-10-03 | PCSA | Grant (A) | — | $0 | EDGAR |
| 2025-09-18 | PCSA | — | — | $0 | EDGAR |
| 2025-07-28 | PCSA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.